Evaluating How to Monitor Immune Response After Clinical Trials to Ensure Continued Efficacy & Identify Responders to Therapy
- Implementing longitudinal immune monitoring strategies such as T-cell profiling and cytokine analysis to track durability of response post-trial
- Identifying predictive and pharmacodynamic biomarkers that distinguish responders from non-responders and detect early signs of relapse
- Integrating real-world evidence and digital health tools to support ongoing efficacy assessment and personalised follow-up strategies